Abstract
Insulin-positive (+) cells (IPCs), detected in multiple organs, are of great interest as a probable alternative to ameliorate pancreatic beta-cells dysfunction and insulin deficiency in diabetes. Liver is a potential source of IPCs due to it common embryological origin with pancreas. We previously demonstrated the presence of IPCs in the liver of healthy and diabetic rats, but detailed description and analysis of the factors, which potentially can induced ectopic hepatic expression of insulin in type 1 (T1D) and type 2 diabetes (T2D), were not performed. In present study we evaluate mass of hepatic IPCs in the rat models of T1D and T2D and discuss factors, which may stimulate it generation: glycaemia, organ injury, involving of hepatic stem/progenitor cell compartment, expression of transcription factors and inflammation. Quantity of IPCs in the liver was up by 1.7-fold in rats with T1D and 10-fold in T2D compared to non-diabetic (ND) rats. We concluded that ectopic hepatic expression of insulin gene is activated by combined action of a number of factors, with inflammation playing a decision role.
Funder
IIP UB RAS: Institute Immunology and Physiology Ural Branch Russian Academy of Science
Publisher
Public Library of Science (PLoS)
Reference80 articles.
1. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040;K. Ogurtsova;Diabetes Res Clin Pract,2017
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus;Diabetes Care,2009
3. Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance;B. Saberzadeh-Ardestani;Cell J,2018
4. Insulin resistance and type 2 diabetes;R. Taylor;Diabetes,2012
5. The time is right for a new classification system for diabetes: rationale and implications of the β-cell–centric classification schema;S.S. Schwartz;Diabetes Care,2016